======= ZRANB1 =======
== Gene Information ==
* **Official Symbol**: ZRANB1
* **Official Name**: zinc finger RANBP2-type containing 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54764|54764]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UGI0|Q9UGI0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZRANB1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZRANB1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/611749|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Specifically hydrolyzes 'Lys-29'-linked and 'Lys-33'- linked diubiquitin. Also cleaves 'Lys-63'-linked chains, but with 40-fold less efficiency compared to 'Lys-29'-linked ones. Positive regulator of the Wnt signaling pathway that deubiquitinates APC protein, a negative regulator of Wnt-mediated transcription. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the stress fiber dynamics and cell migration. May also modulate TNF-alpha signaling. {ECO:0000269|PubMed:18281465, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22157957, ECO:0000269|PubMed:23827681}.
|OTU|
|protein K33-linked deubiquitination|
|protein K29-linked deubiquitination|
|protein deubiquitination involved in ubiquitin-dependent protein catabolic process|
|K63-linked polyubiquitin modification-dependent protein binding|
|protein K63-linked deubiquitination|
|thiol-dependent ubiquitinyl hydrolase activity|
|thiol-dependent ubiquitin-specific protease activity|
|positive regulation of Wnt signaling pathway|
|protein deubiquitination|
|protein modification by small protein removal|
|cell-cell signaling by wnt|
|Wnt signaling pathway|
|regulation of Wnt signaling pathway|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|regulation of cell morphogenesis|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|protein catabolic process|
|intracellular membrane-bounded organelle|
|cellular macromolecule catabolic process|
|cell migration|
|protein modification by small protein conjugation or removal|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|regulation of anatomical structure morphogenesis|
|cell motility|
|localization of cell|
|cytoskeleton organization|
|cell-cell signaling|
|proteolysis|
|locomotion|
|movement of cell or subcellular component|
|positive regulation of signal transduction|
|organic substance catabolic process|
|cellular catabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.28|
|[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.76|
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.79|
|[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.82|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.95|
^Gene^Correlation^
|[[:human genes:h:hectd1|HECTD1]]|0.461|
|[[:human genes:m:med13l|MED13L]]|0.42|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6916
* **Expression level (log2 read counts)**: 5.71
{{:chemogenomics:nalm6 dist.png?nolink |}}